Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,715,098 papers from all fields of science
Search
Sign In
Create Free Account
Haploidentical
Known as:
Haploidentical Donor
A donor who has only one haplotype in common with the recipient.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
S. Piemontese
,
F. Ciceri
,
+12 authors
O. B. O. H. L. S. O. S. Transplantation
Journal of Hematology & Oncology
2017
Corpus ID: 1237153
BackgroundIn the absence of a HLA-matched related or matched unrelated donor, allogeneic stem cell transplantation (allo-SCT…
Expand
Review
2008
Review
2008
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation
A. Velardi
,
L. Ruggeri
,
+5 authors
O. B. O. H. L. S. O. S. Transplantation
Seminars in Immunopathology
2008
Corpus ID: 19398339
Although the optimal donor for allogeneic hematopoietic stem cell transplantation is a human leukocyte antigen (HLA)-matched…
Expand
2007
2007
Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
K. Palmer
,
T. Green
,
+6 authors
R. Buckley
Journal of Allergy and Clinical Immunology
2007
Corpus ID: 21628797
Highly Cited
2005
Highly Cited
2005
In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation
Y. Kanda
,
K. Oshima
,
+10 authors
H. Hirai
Transplantation
2005
Corpus ID: 30539189
Background. Alemtuzumab, a humanized monoclonal antibody directed against human CD52, has a strong lympholytic effect. This study…
Expand
Review
2004
Review
2004
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
L. Ruggeri
,
M. Capanni
,
+8 authors
A. Velardi
Blood Cells, Molecules & Diseases
2004
Corpus ID: 7851497
Highly Cited
2002
Highly Cited
2002
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem…
민유홍
,
정준원
2002
Corpus ID: 115230142
Highly Cited
2000
Highly Cited
2000
Soluble HLA levels in early pregnancy after in vitro fertilization.
K. Pfeiffer
,
V. Rebmann
,
+4 authors
H. Grosse-wilde
Human Immunology
2000
Corpus ID: 22776035
Review
2000
Review
2000
Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC)
W. Vogel
,
S. Scheding
,
L. Kanz
,
W. Brugger
Stem Cells
2000
Corpus ID: 20439018
Recently, a number of devices have been developed for the positive selection of CD34+ peripheral blood progenitor cells (PBPC…
Expand
Highly Cited
1997
Highly Cited
1997
Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation
M. Benkerrou
,
F. Le Deist
,
+5 authors
A. Fischer
European Journal of Immunology
1997
Corpus ID: 8987386
Recently, an inherited syndrome characterized by nonmalignant lymphoprolif‐eration with autoimmune manifestations, caused by…
Expand
Highly Cited
1985
Highly Cited
1985
Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection.
M. Bozdech
,
P. Sondel
,
+7 authors
R. Hong
Experimental Hematology
1985
Corpus ID: 35594376
A total of 41 patients with hematologic malignancies (other than acute leukemia in relapse) received allogeneic bone marrow…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE